Andrew Hessel

Distinguished Research Scientist, Bio/Nano Research Group, Autodesk Research

Andrew Hessel is a Distinguished Researcher with the Bio/Nano Research Group at Autodesk Inc. in San Francisco and a futurist in genomic technologies. Working as a connector and catalyst in biotechnology and synthetic biology, he helps industry, academic, and authorities better understand the rapid changes happening in life science. He also is the founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to produce open source viral therapies for cancer. He is a fellow at the University of Ottawa, Institute for Science, Society and Policy, and the former co-chair of bioinformatics and biotechnology at Singularity University.